Xiao-Qing Song
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao-Qing Song has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Lan Fang
Department of Surgery, Sir Run Run Shaw Hospital Affiliated to School of Medicine, Zhejiang, University, Hangzhou, China
1 shared publicationYang Ou-Yang
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
1 shared publicationZi-Xian Dong
Department of Breast Surgery, the First Hospital of China Medical University, Shenyang, China
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (10) , 6653-6666
Intratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis
Background: Triple-negative breast cancer (TNBC) is characterized by heterogeneity and metabolic reprogramming. Disulfidptosis represents a new category of regulated cell death that is mediated by cystine and cysteine metabolism. However, the underlying mechanism related to the heterogeneity of TNBC disulfidptosis remains unclear. In this study, we aimed to analyze whether disulfidptosis exhibits heterogeneity in TNBC. Methods: Initial molecular subtyping was performed via K-means clustering. Subsequent subtype characterization included enrichment analysis, differential activity score (DA score) analysis, and in vitro drug sensitivity assays targeting disulfidptosis pathways. The prognostic model was derived through univariate Cox regression followed by least absolute shrinkage and selection operator (LASSO) regression of disulfidptosis-associated genes and metabolites. The prediction model was graphically displayed as a nomogram. Results: Through bioinformatics analysis of a TNBC multiomic dataset (n=465), we divided TNBCs into two disulfidptosis-related subtypes: cluster 1 and cluster 2. Compared with cluster 2, cluster 1 had an activated pentose phosphate pathway, an immunosuppressive microenvironment and a poor prognosis. We further confirmed that TNBC cell lines in cluster 1 were more sensitive to disulfidptosis induced by glucose deprivation or the inhibition of GLUT1. Moreover, the disulfidptosis-associated genes and metabolites-based predictive model demonstrated robust predictive performance. Conclusions: Taken together, our research demonstrated the heterogeneity of TNBC disulfidptosis and presented a promising treatment strategy for targeting disulfidptosis in TNBC.
- 1 October 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (10) , 6653-6666
Open AccessIntratumoral disulfidptosis heterogeneity in triple-negative breast cancer, a multiomics integration analysis
Background: Triple-negative breast cancer (TNBC) is characterized by heterogeneity and metabolic reprogramming. Disulfidptosis represents a new category of regulated cell death that is mediated by cystine and cysteine metabolism. However, the underlying mechanism related to the heterogeneity of TNBC disulfidptosis remains unclear. In this study, we aimed to analyze whether disulfidptosis exhibits heterogeneity in TNBC. Methods: Initial molecular subtyping was performed via K-means clustering. Subsequent subtype characterization included enrichment analysis, differential activity score (DA score) analysis, and in vitro drug sensitivity assays targeting disulfidptosis pathways. The prognostic model was derived through univariate Cox regression followed by least absolute shrinkage and selection operator (LASSO) regression of disulfidptosis-associated genes and metabolites. The prediction model was graphically displayed as a nomogram. Results: Through bioinformatics analysis of a TNBC multiomic dataset (n=465), we divided TNBCs into two disulfidptosis-related subtypes: cluster 1 and cluster 2. Compared with cluster 2, cluster 1 had an activated pentose phosphate pathway, an immunosuppressive microenvironment and a poor prognosis. We further confirmed that TNBC cell lines in cluster 1 were more sensitive to disulfidptosis induced by glucose deprivation or the inhibition of GLUT1. Moreover, the disulfidptosis-associated genes and metabolites-based predictive model demonstrated robust predictive performance. Conclusions: Taken together, our research demonstrated the heterogeneity of TNBC disulfidptosis and presented a promising treatment strategy for targeting disulfidptosis in TNBC.